Abstract:Background: Endoglin (CD105) is a cytokine that modulates angiogenesis by regulating different cellular functions, including endothelial proliferation, differentiation, migration and formation of microvessels. CD105 is expressed strongly in the tumor vasculature, and intratumoral microvessel density (IMVD), as determined by the use of antibodies to CD105, it has been found to be an important prognostic indicator for outcome in various malignances. This study aims to determine if the clinical outcome of children with neuroblastoma is correlated with IMVD, as determined by CD105 staining and other prognostic factors. Procedure: Tumor tissue specimens from 38 patients with peripheral neuroblastic tumors who underwent surgical resection or biopsy of their primary tumor without any preoperative therapy were retrospectively reviewed. IMVD was identified immunohistochemically using monoclonal antibodies against CD105. Prognostic factors, such as the MYCN oncogene, disease stage, histopathology and age, were correlated with outcome. Results: Among 38 examined specimens, the median IMVD value was 23.2 (15.1-28.4). The IMVD identified by CD105 was significantly higher in patients with unfavorable histology, metastatic disease, MYCN amplification and COG high risk group. ROC analysis was used to find significant IMVD level regarding EFS. The cut-off >18 was selected according to the greatest sensitivity (100%) and specificity (68.42%). The multivariate Cox proportional hazards analysis demonstrated that MYCN amplification and IMVD were significant prognostic factors in predicting EFS (hazard ratio for MYCN amplification: 3.61; 95% CI: 1.20-10.90; P = 0.023 and for IMVD: 1.05; 95% CI: 1.00-1.09; P = 0.037). Conclusion: IMVD determined by CD105 appeared to be an independent prognostic factor for neuroblastoma.

Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy

Endoglin for tumor imaging and targeted cancer therapy.

Endoglin in Angiogenesis and Vascular Diseases

Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis

Endoglin Promotes Endothelial Cell Proliferation and Tgf-Beta/Alk1 Signal Transduction

Deficiency for Endoglin in Tumor Vasculature Weakens the Endothelial Barrier to Metastatic Dissemination.

Data from Matrix Metalloproteinase-14 (Mt1-Mmp)–mediated Endoglin Shedding Inhibits Tumor Angiogenesis

Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma

Endoglin (CD 105) as a potential prognostic factor in neuroblastoma

Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: tissue microarray analysis and association with prognostic significance.

Endoglin as an Adhesion Molecule in Mature and Progenitor Endothelial Cells: A Function Beyond TGF-β

Endocan: A New Marker for Cancer and a Target for Cancer Therapy.

Prognostic Value of Endoglin-Assessed Microvessel Density in Cancer Patients: a Systematic Review and Meta-Analysis.

Endoglin regulates the integrity of the bone marrow vasculature

Endoglin is Dispensable for Vasculogenesis, but Required for Vascular Endothelial Growth Factor-Induced Angiogenesis

Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105

Endoglin Haploinsufficiency Reduces Radiation-Induced Fibrosis and Telangiectasia Formation in Mouse Kidneys.

Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches.

Novel Protein Interactions with Endoglin and Activin Receptor-like Kinase 1: Potential Role in Vascular Networks.

Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo

Multimodality Molecular Imaging of CD105 (endoglin) Expression.